Elisa T. Helbig

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau et al. · The Lancet Respiratory Medicine · 2021 · 352 citations · Full text

Vaccination, Immunodeficiencies, Immunology +6

Complement activation induces excessive T cell cytotoxicity in severe COVID-19

Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro et al. · Cell · 2021 · 216 citations · Full text

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 212 citations · Full text

Accredited Diagnostic Parameters, Prognosis, Immunology +17

Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses

Matteo Ugolini, Jenny Gerhard, Sanne Burkert et al. · Nature Immunology · 2018 · 168 citations · Full text

Vaccination, Toll-like Receptors, Adaptive Immune System +11

Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months

Fridolin Steinbeis, Charlotte Thibeault, Felix Doellinger et al. · Respiratory Medicine · 2021 · 105 citations · Full text

Observational Longitudinal Study, Respiratory Diseases, Covid-19 Pandemic +9